Applied Filters
GE Healthcare files patent lawsuit against Bio-Rad
American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.
Allele Biotech partners with Scientist.com to develop nanoantibodies
US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications.
Boehringer in research collaboration with Domain Therapeutics
German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics.
NHS to save £300m in biosimilar adalimumab deals
The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug.
New policies weakening IP innovation incentives: report
Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report.
Scientists want CRISPR regulation amid reports of foetus gene-editing
Scientists have urged policymakers to implement a regulatory framework governing the use of CRISPR technology in humans, following reports that a Chinese scientist has successfully created ‘edited’ twins.
CRISPR tech market to reach $1.72m by 2023: report
The global CRISPR technology market is expected to reach $1.72 million in value by 2023, up from 2018’s predicted figure of $562 million, according to a report released this month.
Life sciences partners join Saul Ewing’s Boston office
Saul Ewing Arnstein & Lehr has strengthened its Boston office with the addition of two life sciences partners from Hamilton, Brook, Smith & Reynolds.
10x Genomics sued over cell research tools
Genome sequencing company 10x Genomics has been accused of infringing 11 patents covering cell research and analysis tools.
Brexit draft deal: a welcome step but more certainty needed, say lawyers
While the pharmaceutical industry has welcomed the draft Withdrawal Agreement for the UK’s departure from the EU, more clarity is still needed, lawyers have told LSIPR.
